quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:30:17·1886d
INSIDERFiling
NTN Buzztime, Inc. logo

SEC Form 4: M Sandra Gurrola disposed of $553 worth of Common Stock (115 units at $4.81), decreasing ownership by 0.41% to 27,827 units

NTN· NTN Buzztime, Inc.
Consumer Services
Original source

Companies

  • NTN
    NTN Buzztime, Inc.
    Consumer Services

Related

  • SEC1849d
    NTN Buzztime, Inc. filed SEC Form 8-K: Completion Of Acquisition Or Disposition Of Assets, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits
  • INSIDER1854d
    SEC Form 4: Allen Wolff disposed of $26,550 worth of Common Stock (9,944 units at $2.67), decreasing direct ownership by 7% to 128,520 units
  • INSIDER1854d
    SEC Form 4: M Sandra Gurrola disposed of $16,271 worth of Common Stock (6,094 units at $2.67), decreasing direct ownership by 22% to 21,617 units
  • SEC1857d
    SEC Form 8-K filed by NTN Buzztime, Inc.
  • PR1857d
    NTN Buzztime Announces Proposed Reverse Stock Split Ratio and Anticipated Closing of Merger
  • INSIDER1858d
    SEC Form 4: M Sandra Gurrola disposed of $409 worth of Common Stock (116 units at $3.53), decreasing direct ownership by 0.42% to 27,711 units
  • INSIDER1858d
    SEC Form 4: Allen Wolff disposed of $731 worth of Common Stock (207 units at $3.53), decreasing direct ownership by 0.15% to 138,464 units
  • PR1865d
    NTN Buzztime Announces Approval of Merger with Brooklyn ImmunoTherapeutics by Stockholders at Special Meeting
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022